|
1
|
Jemal A, Siegel R, Ward E, et al: Cancer
statistics, 2008. CA Cancer J Clin. 58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Masters G: The clinical presentation of
small cell lung cancerLung Cancer: Principles and Practice. Pass
HI, Carbone DP, Johnson DH, Minna JD and Turrisi AT III: 3rd.
Lippincott Williams & Wilkins; Philadelphia, PA: pp. 304–314.
2005
|
|
3
|
Jackman DM and Johnson BE: Small-cell lung
cancer. Lancet. 366:1385–1396. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Turrisi AT III, Kim K, Blum R, et al:
Twice-daily compared with once-daily thoracic radiotherapy in
limited small-cell lung cancer treated concurrently with cisplatin
and etoposide. N Engl J Med. 340:265–271. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sorensen M, Pijls-Johannesma M, Felip E,
et al: Small-cell-lung cancer: ESMO Clinical Practice Guidelines
for diagnosis, treatment and follow-up. Ann Oncol. 21 (Suppl
5):v120–v125. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sambrook RJ and Girling DJ: A national
survey of the chemotherapy regimens used to treat small cell lung
cancer (SCLC) in the United Kingdom. Br J Cancer. 84:1447–1452.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jiang L, Yang KH, Guan QL, et al:
Cisplatin plus etoposide versus other platin-based regimens for
patients with extensive small-cell lung cancer: a systematic review
and meta-analysis of randomised, controlled trials. Intern Med J.
42:1297–1309. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Brade WP, Herdrich K and Varini M:
Ifosfamide - pharmacology, safety and therapeutic potential. Cancer
Treat Rev. 12:1–47. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Havemann K, Wolf M, Drings P, et al:
Experience of a German multicenter study group with ifosfamide in
small cell lung cancer. Semin Oncol. 16 (Suppl 3):9–18.
1989.PubMed/NCBI
|
|
10
|
Thatcher N, Cerny T, Stout R, et al:
Ifosfamide, etoposide, and thoracic irradiation therapy in 163
patients with unresectable small cell lung cancer. Cancer.
60:2382–2387. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wolf M, Havemann K, Holle R, et al:
Cisplatin/etoposide versus ifosfamide/etoposide combination
chemotherapy in small-cell lung cancer: a multicenter German
randomized trial. J Clin Oncol. 5:1880–1889. 1987.PubMed/NCBI
|
|
12
|
Evans WK, Stewart DJ, Shepherd FA, et al:
VP-16, ifosfamide and cisplatin (VIP) for extensive small cell lung
cancer. Eur J Cancer. 30A:299–303. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Loehrer PJ, Rynard S, Ansari R, et al:
Etoposide, ifosfamide, and cisplatin in extensive small cell lung
cancer. Cancer. 69:669–673. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Miyamoto H, Nakabayashi T, Isobe H, et al:
A phase III comparison of etoposide/cisplatin with or without added
ifosfamide in small-cell lung cancer. Oncology. 49:431–435. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Loehrer PJ Sr, Ansari R, Gonin R, et al:
Cisplatin plus etoposide with and without ifosfamide in extensive
small-cell lung cancer: a Hoosier Oncology Group study. J Clin
Oncol. 13:2594–2599. 1995.PubMed/NCBI
|
|
16
|
Wolff AC, Ettinger DS, Neuberg D, et al:
Phase II study of ifosfamide, carboplatin, and oral etoposide
chemotherapy for extensive-disease small-cell lung cancer: an
Eastern Cooperative Oncology Group pilot study. J Clin Oncol.
13:1615–1622. 1995.PubMed/NCBI
|
|
17
|
Glisson B, Lee JS, Palmer J, et al:
Cisplatin, ifosfamide, and prolonged oral etoposide in the
treatment of patients with extensive small cell lung carcinoma.
Cancer. 82:301–308. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hand S, Baker J, Smith AP, et al:
Outpatient intensive chemotherapy for small cell lung cancer: five
years experience of modified ‘ICE’ ifosfamide carboplatin and
etoposide. Clin Oncol (R Coll Radiol). 14:367–371. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou H, Wang A, Huang Z, et al: Randomized
clinical trial of IEP and EP regimens in the treatment of patients
with small cell lung cancer. Chin J Lung Cancer. 7:240–242.
2004.(In Chinese).
|
|
20
|
Wu C, Qi H, Dai Y, et al: Therapeutic
efficacy of chemotherapy with VIP for small cell lung cancer. Chin
J Lung Cancer. 7:151–153. 2004.(In Chinese).
|
